La Jolla Institute renews longtime collaboration with Kyowa Kirin Pharmaceutical Research, Inc.
LA JOLLA, CA—La Jolla Institute for Immunology (LJI) and Kyowa Kirin Pharmaceutical Research, Inc. (KKR), a wholly-owned subsidiary of Kyowa
LA JOLLA, CA—La Jolla Institute for Immunology (LJI) and Kyowa Kirin Pharmaceutical Research, Inc. (KKR), a wholly-owned subsidiary of Kyowa
LA JOLLA, CA—Dr. Matthias von Herrath, M.D., who founded the Type 1 Diabetes Center at La Jolla Institute for Immunology
Rana Herro, Ph.D., 2017 SPARK finalist, is proving the power of philanthropy and SPARK. Not only did she potentially discover
Spotting cancers earlier could save millions of lives every year but most of the currently used cancer screening tests fail
In type 1 diabetes (T1D) the body’s own immune system attacks and destroys the insulin-producing beta cells in the pancreas.
The immune system has the uncanny ability to identify and hold on to infected cells, forming so-called cell doublets, which
What we eat not only feeds us, but also the bacteria that call our intestines home. When we consume an
LA JOLLA, CA— Among the flood of research papers published by scientists and scholars in academic journals year in and
Inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis afflict over a million Americans. Currently, clinicians have to rely
Understanding how our immune system recognizes and responds to cancer is essential for developing treatments that augment our natural defenses.
DICE contains a trove of data that will be critical for deciphering how this natural genetic variation shapes the immune